Literature DB >> 9512107

Clinical manifestations of systemic sclerosis.

V D Steen1.   

Abstract

Systemic sclerosis is a multisystem disease characterized by inflammation and fibrosis of many organs. There are two major subsets, limited cutaneous (the old CREST syndrome) and diffuse cutaneous scleroderma. The major difference is the pace of disease. Limited scleroderma patients often have a long history of Raynaud's phenomenon before other symptoms. They have skin thickening limited to hands and frequently have problems with digital ulcers and esophageal dysmotility. Although generally a milder form than diffuse scleroderma, they can have life-threatening complications from small intestine hypomotility and pulmonary hypertension. Diffuse scleroderma patients have a much more acute onset, with many constitutional symptoms, arthritis, carpal tunnel syndrome, and marked swelling of hands and legs. They get widespread skin thickening, progressing from their fingers to their trunk. Internal organ problems, including gastrointestinal and pulmonary fibrosis, are common, but severe life-threatening involvement of the heart and kidneys occurs. Understanding the type of disease that occurs in these two subsets will enable the physician to anticipate problems, aggressively treat those that can be treated, and give the patient a better understanding of their disease.

Entities:  

Mesh:

Year:  1998        PMID: 9512107     DOI: 10.1016/s1085-5629(98)80062-x

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  18 in total

Review 1.  A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.

Authors:  E Hachulla; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

2.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

3.  Relationship between Peripheral Arterial Stiffness and Estimated Pulmonary Pressure by Echocardiography in Systemic Sclerosis.

Authors:  Burabha Pussadhamma; Wannipa Suwannakrua; Panorkwan Toparkngarm; Chaiyasith Wongvipaporn; Chingching Foocharoen; Ratanavadee Nanagara
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

Review 4.  [Systemic sclerosis - diagnosis and classification].

Authors:  E Genth; T Krieg
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

5.  Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.

Authors:  Nand Lal Sharma; Vikram K Mahajan; Nitin Ranjan; Vikas Chander Sharma; Mudita Gupta
Journal:  Clin Rheumatol       Date:  2009-10-17       Impact factor: 2.980

6.  Connective Tissue Disease-associated Interstitial Lung Disease: A review.

Authors:  Markus Gutsche; Glenn D Rosen; Jeffrey J Swigris
Journal:  Curr Respir Care Rep       Date:  2012-09-21

7.  Immediate Effect of Xylitol Chewing Gum and Mouth Rinse on Salivary Levels of Mutans Streptococci in Adults with Systemic Sclerosis: A Pilot Study.

Authors:  Hon K Yuen; Caroline Westwater; Justin Degarmo; Dipankar Bandyopadhyay
Journal:  J Exp Integr Med       Date:  2012-01-01

8.  Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.

Authors:  Alexandra B Wiese; Veronica J Berrocal; Daniel E Furst; James R Seibold; Peter A Merkel; Maureen D Mayes; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

Review 9.  The heart in scleroderma.

Authors:  Hunter C Champion
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

10.  Low-dose naltrexone for pruritus in systemic sclerosis.

Authors:  Tracy Frech; Kirsten Novak; Monica P Revelo; Maureen Murtaugh; Boaz Markewitz; Nathan Hatton; Mary Beth Scholand; Edward Frech; David Markewitz; Allen D Sawitzke
Journal:  Int J Rheumatol       Date:  2011-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.